UnitedHealth Group Inc (NYSE:UNH) had its target price increased by equities researchers at Piper Jaffray Companies to $228.00 in a research report issued to clients and investors on Tuesday, October 17th, The Fly reports. The brokerage currently has an “overweight” rating on the healthcare conglomerate’s stock. Piper Jaffray Companies’ price target would suggest a potential upside of 9.01% from the stock’s current price.
Several other research firms also recently commented on UNH. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, October 10th. Morgan Stanley increased their price objective on shares of UnitedHealth Group from $202.00 to $210.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 28th. ValuEngine downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 5th. Sanford C. Bernstein reiterated an “outperform” rating and set a $190.00 price objective on shares of UnitedHealth Group in a research note on Monday, July 10th. Finally, Deutsche Bank AG increased their price objective on shares of UnitedHealth Group from $187.00 to $197.00 and gave the stock a “buy” rating in a research note on Thursday, July 13th. Three analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $215.27.
UnitedHealth Group (UNH) traded up 0.77% during mid-day trading on Tuesday, hitting $209.15. The stock had a trading volume of 4,345,993 shares. UnitedHealth Group has a one year low of $136.22 and a one year high of $211.70. The firm’s 50-day moving average is $198.15 and its 200 day moving average is $186.99. The stock has a market cap of $206.85 billion, a PE ratio of 23.75 and a beta of 0.63.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.57 by $0.09. The company had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a net margin of 5.09% and a return on equity of 22.03%. The company’s revenue was up 8.7% on a year-over-year basis. During the same period in the prior year, the firm earned $2.17 earnings per share. Equities research analysts expect that UnitedHealth Group will post $9.99 EPS for the current year.
COPYRIGHT VIOLATION NOTICE: “UnitedHealth Group Inc (NYSE:UNH) PT Raised to $228.00 at Piper Jaffray Companies” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this story on another website, it was illegally stolen and reposted in violation of United States and international copyright law. The correct version of this story can be accessed at https://www.dispatchtribunal.com/2017/10/26/piper-jaffray-companies-raises-unitedhealth-group-incorporated-unh-price-target-to-228-00.html.
In other news, insider Thomas E. Roos sold 975 shares of UnitedHealth Group stock in a transaction on Thursday, October 19th. The shares were sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the sale, the insider now owns 24,630 shares in the company, valued at approximately $5,060,726.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total transaction of $969,900.00. Following the completion of the sale, the director now owns 76,058 shares of the company’s stock, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 77,149 shares of company stock valued at $15,182,242. Company insiders own 0.89% of the company’s stock.
Several large investors have recently added to or reduced their stakes in UNH. Waldron LP increased its stake in shares of UnitedHealth Group by 153.1% in the 1st quarter. Waldron LP now owns 5,765 shares of the healthcare conglomerate’s stock valued at $944,000 after acquiring an additional 3,487 shares in the last quarter. WASHINGTON TRUST Co bought a new stake in shares of UnitedHealth Group in the 1st quarter valued at $235,000. Blue Fin Capital Inc. bought a new stake in shares of UnitedHealth Group in the 1st quarter valued at $205,000. Webster Bank N. A. increased its stake in shares of UnitedHealth Group by 27.0% in the 1st quarter. Webster Bank N. A. now owns 913 shares of the healthcare conglomerate’s stock valued at $149,000 after acquiring an additional 194 shares in the last quarter. Finally, Adell Harriman & Carpenter Inc. increased its stake in shares of UnitedHealth Group by 36.3% in the 1st quarter. Adell Harriman & Carpenter Inc. now owns 13,096 shares of the healthcare conglomerate’s stock valued at $2,148,000 after acquiring an additional 3,485 shares in the last quarter. Institutional investors own 86.09% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.